Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies ; volume:10 ; number:6 ; day:26 ; month:11 ; year:2008 ; pages:1-11 ; date:12.2008
Breast cancer research ; 10, Heft 6 (26.11.2008), 1-11, 12.2008

Creator: Kelemen, Linda E.

Contributor: Couch, Fergus J.
Ahmed, Shahana
Dunning, Alison M.
Pharoah, Paul DP
Easton, Douglas F.
Fredericksen, Zachary S.
Vierkant, Robert A.
Pankratz, V Shane
Goode, Ellen L.
Scott, Christopher G.
Rider, David N.
Wang, Xianshu
Cerhan, James R.
Vachon, Celine M.
SpringerLink (Online service)

DOI: 10.1186/bcr2201

URN: urn:nbn:de:1111-201603241958

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kelemen, Linda E.
Couch, Fergus J.
Ahmed, Shahana
Dunning, Alison M.
Pharoah, Paul DP
Easton, Douglas F.
Fredericksen, Zachary S.
Vierkant, Robert A.
Pankratz, V Shane
Goode, Ellen L.
Scott, Christopher G.
Rider, David N.
Wang, Xianshu
Cerhan, James R.
Vachon, Celine M.
SpringerLink (Online service)

Other Objects (12)

Clinical software development for the Web: lessons learned from the BOADICEA project

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Clinical software development for the Web: lessons learned from the BOADICEA project

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Clinical software development for the Web: lessons learned from the BOADICEA project

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Clinical software development for the Web: lessons learned from the BOADICEA project

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Clinical software development for the Web: lessons learned from the BOADICEA project

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Clinical software development for the Web: lessons learned from the BOADICEA project

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Related objects

Reset password